Matthias Weckesser

Differentiation of Malignant and Benign Cardiac Tumors Using ¹⁸F-FDG PET/CT

Kambiz Rahbar, Harald Seifarth, Michael Schäfers et al. · Journal of Nuclear Medicine · 2012 · 262 citations · Full text

Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial

Ulrich Dührsen, Stefan Müller, Bernd Hertenstein et al. · Journal of Clinical Oncology · 2018 · 238 citations

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

Carsten Kobe, Markus Dietlein, Jeremy Franklin et al. · Blood · 2008 · 203 citations · Full text

O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours

Matthias Weckesser, Karl‐Josef Langen, Christian Rickert et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2005 · 191 citations

Positron Emission Tomography, Neuro-oncology, Nuclear Medicine +13

Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate Cancer

Kambiz Rahbar, Axel Bode, Matthias Weckesser et al. · Clinical Nuclear Medicine · 2016 · 182 citations